DN is associated with multiple hazardous ambient factors such as high glucose, advanced glycation end products (AGEs), hypertension, and dyslipidemia, which can activate TGF-β signaling through TGF-β-dependent and independent mechanisms. Here, TGFB1 is linked to metabolic syndrome.